| dc.contributor.author | Smith, SG | en_US |
| dc.contributor.author | Sestak, I | en_US |
| dc.contributor.author | Howell, A | en_US |
| dc.contributor.author | Forbes, J | en_US |
| dc.contributor.author | Cuzick, J | en_US |
| dc.date.accessioned | 2017-08-21T14:21:14Z | |
| dc.date.available | 2017-04-15 | en_US |
| dc.date.issued | 2017-08-10 | en_US |
| dc.date.submitted | 2017-04-21T16:25:38.952Z | |
| dc.identifier.issn | 0732-183X | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/25333 | |
| dc.description.sponsorship | AstraZeneca (Inst) | en_US |
| dc.format.extent | 2666 - + | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | JOURNAL OF CLINICAL ONCOLOGY | en_US |
| dc.rights | Licensed under the Creative Commons Attribution 4.0 License. | |
| dc.title | Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I) | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2017 by American Society of Clinical Oncology. | |
| dc.identifier.doi | 10.1200/JCO.2016.71.7439 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407001500013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 23 | en_US |
| pubs.notes | 6 months | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 35 | en_US |
| qmul.funder | Poison or prevention: do cognitive representations of breast cancer chemoprevention affect adherence::Cancer Research UK | en_US |
